Stay updated on Rituximab in Eosinophilic Granulomatosis Clinical Trial
Sign up to get notified when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.

Latest updates to the Rituximab in Eosinophilic Granulomatosis Clinical Trial page
- Check2 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%
- Check9 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check16 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with a comprehensive list of drug information related to eosinophilic granulomatosis with polyangiitis, while some previous location and drug information has been removed.SummaryDifference13%
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Rituximab in Eosinophilic Granulomatosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.